Copeland Capital discloses 5.17% U.S. Physical Therapy (USPH) stake

Rhea-AI Filing Summary

Copeland Capital Management, LLC has filed a Schedule 13G reporting a passive ownership stake in U.S. Physical Therapy, Inc. common stock. The firm reports beneficial ownership of 786,114 shares, representing 5.17% of the outstanding common stock as of the event date.

Copeland Capital has sole voting power over 512,506 shares and shared voting power over 126,549 shares. It reports no sole dispositive power and shared dispositive power over all 786,114 shares. The securities are certified as being held in the ordinary course of business, not for the purpose of changing or influencing control of the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/29/2026 - 03:11 PM Learn about SEC filing dates

FAQ

What percentage of U.S. Physical Therapy (USPH) does Copeland Capital Management report owning?

Copeland Capital Management reports beneficial ownership of 5.17% of U.S. Physical Therapy’s common stock. This corresponds to 786,114 shares, as disclosed in the Schedule 13G, crossing the 5% threshold that requires institutional investors to make this type of ownership filing.

How many U.S. Physical Therapy (USPH) shares does Copeland Capital Management control voting power over?

Copeland Capital reports sole voting power over 512,506 shares and shared voting power over 126,549 shares of U.S. Physical Therapy. These figures show how many shares it can vote independently versus in conjunction with others, as detailed in the ownership section.

What is the aggregate number of U.S. Physical Therapy (USPH) shares beneficially owned according to this Schedule 13G?

The Schedule 13G states that Copeland Capital beneficially owns 786,114 shares of U.S. Physical Therapy common stock. This aggregate figure underpins the reported 5.17% ownership interest and includes all shares over which it has sole or shared voting or dispositive power.

Is Copeland Capital Management’s stake in U.S. Physical Therapy (USPH) reported as a passive investment?

Yes. The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of U.S. Physical Therapy, indicating a passive investment consistent with Schedule 13G requirements.

Who signed the U.S. Physical Therapy (USPH) Schedule 13G filing and in what capacity?

The filing is signed by Sofia A. Rosala, identified as General Counsel and CCO. Her signature appears under a certification that, after reasonable inquiry, the information in the statement is true, complete, and correct, as of the signature date in late January 2026.

What is the event date triggering this Schedule 13G for U.S. Physical Therapy (USPH)?

The Schedule 13G lists December 31, 2025 as the date of the event requiring the filing. That date generally reflects when Copeland Capital’s beneficial ownership position reached or was measured at the reported 5.17% stake in U.S. Physical Therapy’s common stock.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

U S PHYSICAL THERAPY INC /NV

(Name of Issuer)

Common Stock

(Title of Class of Securities)

90337L108

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 90337L108

1

Names of Reporting Persons

Copeland Capital Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 512,506.00
6	Shared Voting Power 126,549.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 786,114.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

786,114.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.17 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: U S PHYSICAL THERAPY INC /NV
(b)	Address of issuer's principal executive offices: 1300 WEST SAM HOUSTON PARKWAY, SUITE 300, HOUSTON, TX, 77043
Item 2.
(a)	Name of person filing: Sofia A. Rosala
(b)	Address or principal business office or, if none, residence: 161 Washington St, Suite 1325, Conshohocken, PA 19428
(c)	Citizenship: U.S.A
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 90337L108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 786,1114
(b)	Percent of class: 5.17%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 512,506
	(ii) Shared power to vote or to direct the vote: 126,549
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 786,114
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Copeland Capital Management, LLC

Signature:	/s/ Sofia A. Rosala
Name/Title:	General Counsel and CCO
Date:	01/28/2026